GLP-1 Plateau Phases: What to Review Before Changing Your Plan

Phase 1 plateau: adaptation noise

Early-phase plateaus often reflect adaptation, variable routines, or short data windows rather than treatment failure.

This phase requires execution checks first: dose timing, refill continuity, and symptom-driven routine disruption.

Switching strategy too early can create new instability without solving root causes.

A two-week audit window is often more informative than reacting to a few discouraging days.

Sources: [1] [2] [4]

Phase 2 plateau: mid-course friction

In mid-course periods, plateaus are often tied to behavior drift, stress load, sleep disruption, or fragmented follow-up.

A structured review should include intake consistency, activity pattern, and whether symptom burden changed routine quality.

This is usually the highest-value moment for targeted process corrections.

Many mid-course plateaus improve when routine friction is reduced before any medication strategy change is attempted.

Sources: [2] [3] [5]

Phase 3 plateau: maintenance complexity

Maintenance plateaus are rarely solved by urgency alone. They are usually solved by cleaner decision criteria.

Documenting clear continue-adjust-escalate rules can prevent repeated cycling between overreaction and inaction.

• Review long-term adherence trend, not one week.
• Check whether support cadence matches current needs.
• Revisit expectations using maintenance evidence context.
• Clarify next-step criteria before requesting major changes.

Sources: [1] [3] [6]

Bottom line

A plateau is a signal to audit process quality before changing medication strategy.

Use phase-based review, trend data, and provider collaboration to avoid reactive decisions.

Structured audits usually produce better long-term decisions than one-variable interpretations.

Sources: [1] [2] [3]